Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ImmunityBio (IBRX) Return on Assets (2016 - 2025)

ImmunityBio (IBRX) has disclosed Return on Assets for 11 consecutive years, with 0.69% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 42.0% to 0.69% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.69% through Dec 2025, up 42.0% year-over-year, with the annual reading at 0.79% for FY2025, 14.0% up from the prior year.
  • Return on Assets for Q4 2025 was 0.69% at ImmunityBio, up from 0.76% in the prior quarter.
  • The five-year high for Return on Assets was 0.69% in Q4 2025, with the low at 1.49% in Q2 2023.
  • Average Return on Assets over 5 years is 1.18%, with a median of 1.21% recorded in 2022.
  • The sharpest move saw Return on Assets tumbled -43bps in 2023, then surged 70bps in 2025.
  • Over 5 years, Return on Assets stood at 1.02% in 2021, then dropped by -14bps to 1.17% in 2022, then fell by -7bps to 1.25% in 2023, then grew by 11bps to 1.11% in 2024, then soared by 38bps to 0.69% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.69%, 0.76%, and 1.04% for Q4 2025, Q3 2025, and Q2 2025 respectively.